Pfizer (PFE) Finished Goods (2009 - 2019)

Pfizer (PFE) has 11 years of Finished Goods data on file, last reported at $2.3 billion in Q1 2019.

• Finished Goods for Q1 2019 came in at $2.3 billion, down 19.42% year-over-year; the trailing twelve-month figure through Mar 2019 was $2.3 billion (down 19.42% YoY), and the FY2018 annual result was $2.3 billion, down 21.54% from the prior year.
• Finished Goods improved to $2.3 billion in Q1 2019 per PFE's latest filing, from $2.3 billion in the prior quarter.
• Over five years, Finished Goods peaked at $2.9 billion in Q4 2017 and troughed at $1.8 billion in Q2 2015.
• A 5-year average of $2.5 billion and a median of $2.6 billion in 2016 frame the typical range for Finished Goods.
• The sharpest annual moves came in 2015 and 2016: Finished Goods decreased 24.86% in 2015, then surged 49.89% in 2016.
• A 5-year view of Finished Goods shows it stood at $2.7 billion in 2015, then retreated by 15.51% to $2.3 billion in 2016, then increased by 25.73% to $2.9 billion in 2017, then slipped by 21.54% to $2.3 billion in 2018, then gained by 1.11% to $2.3 billion in 2019.
• Business Quant data shows PFE's Finished Goods at $2.3 billion in Q1 2019, $2.3 billion in Q4 2018, and $2.6 billion in Q3 2018.